Javascript must be enabled to continue!
Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
View through CrossRef
Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated serum levels of parathyroid hormone (PTH) with persistently normal serum calcium concentrations after excluding secondary causes of hyperparathyroidism. Urolithiasis and/or nephrocalcinosis may occur in hypercalcemic PHPT, but little is known about these complications in NPHPT. Objectives. To identify occult urolithiasis and nephrocalcinosis in asymptomatic patients with NPHPT and evaluate biochemical markers as risk predictors for the development of renal calcification (RC). Methods. Cross-sectional analysis of 34 patients with no history of urolithiasis and/or nephrocalcinosis. The diagnosis of NPHPT was as follows: elevated serum PTH (reference range: 15–65 pg/mL), normal albumin-corrected serum calcium, normal urinary calcium excretion, serum 25(OH)D >30 ng/mL, eGFR (CKD-EPI) > 60 mL/min/1.73 m2, without intestinal disease, and not on medications such as thiazide diuretics, lithium, bisphosphonates, or denosumab. Patients were categorized according to the presence or absence of RC identified by renal imaging. Their clinical and biochemical characteristics were then compared. Results. The patients had a mean age of 67.97 ± 10.45 years, predominantly postmenopausal women (88.2%); serum PTH, 119.67 ± 64.44 pg/mL; 25(OH)D, 39.00 ± 8.88 ng/dL; 1.25(OH))2D, 74.53 ± 26.37 pg/mL; corrected serum calcium, 9.34 ± 0.62 mg/dL; and 24-hour urinary calcium, 134.87 ± 79.68 mg/day. RC was identified in 26.5% of the patients. There was no difference in anthropometric and clinical parameters, renal function, 25(OH)D, and urinary pH in patients with or without RC. Patients with RC had higher PTH values (176.22 vs. 99.32 pg/mL,
P
= 0.001), 1.25(OH) 2D (96.83 vs. 62.36 pg/mL,
P
= 0.005), and 24-hour urinary calcium (181.9 vs. 117.94 mg/day,
P
= 0.037). Conclusion. Occult renal calcifications are common in NPHPT and are associated with increased serum PTH, 1.25(OH))2D, and 24 h urinary calcium.
Title: Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis
Description:
Normocalcemic primary hyperparathyroidism (NPHPT) is characterized by elevated serum levels of parathyroid hormone (PTH) with persistently normal serum calcium concentrations after excluding secondary causes of hyperparathyroidism.
Urolithiasis and/or nephrocalcinosis may occur in hypercalcemic PHPT, but little is known about these complications in NPHPT.
Objectives.
To identify occult urolithiasis and nephrocalcinosis in asymptomatic patients with NPHPT and evaluate biochemical markers as risk predictors for the development of renal calcification (RC).
Methods.
Cross-sectional analysis of 34 patients with no history of urolithiasis and/or nephrocalcinosis.
The diagnosis of NPHPT was as follows: elevated serum PTH (reference range: 15–65 pg/mL), normal albumin-corrected serum calcium, normal urinary calcium excretion, serum 25(OH)D >30 ng/mL, eGFR (CKD-EPI) > 60 mL/min/1.
73 m2, without intestinal disease, and not on medications such as thiazide diuretics, lithium, bisphosphonates, or denosumab.
Patients were categorized according to the presence or absence of RC identified by renal imaging.
Their clinical and biochemical characteristics were then compared.
Results.
The patients had a mean age of 67.
97 ± 10.
45 years, predominantly postmenopausal women (88.
2%); serum PTH, 119.
67 ± 64.
44 pg/mL; 25(OH)D, 39.
00 ± 8.
88 ng/dL; 1.
25(OH))2D, 74.
53 ± 26.
37 pg/mL; corrected serum calcium, 9.
34 ± 0.
62 mg/dL; and 24-hour urinary calcium, 134.
87 ± 79.
68 mg/day.
RC was identified in 26.
5% of the patients.
There was no difference in anthropometric and clinical parameters, renal function, 25(OH)D, and urinary pH in patients with or without RC.
Patients with RC had higher PTH values (176.
22 vs.
99.
32 pg/mL,
P
= 0.
001), 1.
25(OH) 2D (96.
83 vs.
62.
36 pg/mL,
P
= 0.
005), and 24-hour urinary calcium (181.
9 vs.
117.
94 mg/day,
P
= 0.
037).
Conclusion.
Occult renal calcifications are common in NPHPT and are associated with increased serum PTH, 1.
25(OH))2D, and 24 h urinary calcium.
Related Results
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
Objective: To demonstrate vitamin D deficiency in the general population of Punjab
Study Design: Observational, Cross-Sectional
Place and Duration: Multicentre study co...
Parathyroid Function in Primary Osteoporosis
Parathyroid Function in Primary Osteoporosis
1. Parathyroid hormone and 25-hydroxy-vitamin D concentrations were measured in patients with severe primary osteoporosis and the results were compared with those found in normal s...
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism is a terminology used to describe a group of metabolic disorders characterized by parathyroid hormone resistance. Patients with pseudohypoparathyroidism ha...
Renal Phosphate Loss in Long-Term Kidney Transplantation
Renal Phosphate Loss in Long-Term Kidney Transplantation
Summary
Background and objectives
Renal phosphate wasting occurs early postkidney transplantation as a result of an accumulation of parathyroid h...
A Rare Case of Giant Parathyroid Adenoma in a Rural Tertiary Hospital of North Bengal
A Rare Case of Giant Parathyroid Adenoma in a Rural Tertiary Hospital of North Bengal
A 30-year-old euthyroid male patient presented with a gradually progressive, painless mass in the neck that moved with deglutition, associated with generalized weakness, needing as...
De novo
expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism
De novo
expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism
Abstract
Background.
The factors involved in abnormal parathyroid cell secretory function and growth in patients with pri...
Tooth mobility revealing a brown tumor associated with normocalcemic tertiary hyperparathyroidism: case report and literature review
Tooth mobility revealing a brown tumor associated with normocalcemic tertiary hyperparathyroidism: case report and literature review
Abstract
Background
Brown tumors are rare non neoplastic lesions resulting from abnormal bone metabolism in hyperparathyroidism. They are rarely observed in tertia...
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Objective:
Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other...

